555 related articles for article (PubMed ID: 30687936)
21. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
[TBL] [Abstract][Full Text] [Related]
22. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
23. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
24. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
25. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
26. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
27. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological interventions for treatment-resistant depression in adults.
Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
[TBL] [Abstract][Full Text] [Related]
29. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
30. Benzodiazepines versus placebo for panic disorder in adults.
Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
32. Anticonvulsants for alcohol dependence.
Pani PP; Trogu E; Pacini M; Maremmani I
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008544. PubMed ID: 24523233
[TBL] [Abstract][Full Text] [Related]
33. Alpha₂-adrenergic agonists for the management of opioid withdrawal.
Gowing L; Farrell M; Ali R; White JM
Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
[TBL] [Abstract][Full Text] [Related]
34. Anti-seizure medications for Lennox-Gastaut syndrome.
Brigo F; Jones K; Eltze C; Matricardi S
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
[TBL] [Abstract][Full Text] [Related]
35. Non-steroidal anti-inflammatory drugs for acute low back pain.
van der Gaag WH; Roelofs PD; Enthoven WT; van Tulder MW; Koes BW
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013581. PubMed ID: 32297973
[TBL] [Abstract][Full Text] [Related]
36. Psychosocial interventions for cannabis use disorder.
Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
[TBL] [Abstract][Full Text] [Related]
37. Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M; Al-Bachari S; Weston J; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001415. PubMed ID: 30357813
[TBL] [Abstract][Full Text] [Related]
38. Interventions for pityriasis rosea.
Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
[TBL] [Abstract][Full Text] [Related]
39. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
40. Gabapentin add-on treatment for drug-resistant focal epilepsy.
Panebianco M; Al-Bachari S; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
